Keyword: Teva

News

Sanofi Fined in Plavix Generics Dispute

14.05.2013 - The French Competition Authority fined drugmaker Sanofi €40.6 million ($52.7 million) on Tuesday for "disparaging" generic competition to its Plavix blood thinner. The decision on...

News

Judge Denies FDA Bid to Stay 'Morning-after' Pill Ruling

10.05.2013 - A federal judge in New York on Friday declined to temporarily halt a court order directing the U.S. Food and Drug Administration to make emergency contraception available over the...

News

Bayer HealthCare Integrates Animal Health Acquisition

10.05.2013 - Bayer HealthCare is successfully integrating the recently acquired Teva Animal Health by beginning the process of introducing products to the U.S. market under the Bayer brand...

News

Teva Pharmaceutical Banks on Thrice-weekly Copaxone

02.05.2013 - Teva Pharmaceutical Industries is banking on approval in early 2014 for a new thrice-weekly version of its multiple sclerosis treatment Copaxone to bolster sales ahead of a likely...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...

News

Teva - Lonza Evaluates Biosimilars Opportunity

05.04.2013 - The Teva-Lonza Joint Venture issued the following statement today: The potential to develop, manufacture and market affordable, efficacious and safe biosimilars remains an area of...

News

Obagi Medical Gets Higher Offer from Merz Pharma

02.04.2013 - Neurological and dermatology drugs maker Merz Pharma offered to buy cosmetic products maker Obagi Medical Products for $383.5 million, topping a bid by Canada's Valeant...

News

Roche Stays a Step Ahead of Copycat Drugmakers

25.03.2013 - Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...